Hyperthyroidism Due to Graves Disease After Radiofrequency Ablation

Area of Science:

• Endocrinology
• Minimally Invasive Procedures
• Thyroidology

Background:

• Traditionally, thyroid nodule management involved surgery or radioactive iodine.
• Radiofrequency ablation (RFA) has emerged as a less invasive alternative, particularly for high-risk patients or those avoiding hypothyroidism.
• RFA offers improved quality of life compared to surgery, despite potential insurance barriers.

Observation:

• A patient with a large, symptomatic multinodular goiter underwent successful RFA for two nodules.
• No prior history of thyroid autoimmunity was noted in the patient.
• Eight weeks post-RFA, the patient developed acute hyperthyroidism attributed to Graves disease.

Findings:

• RFA successfully reduced thyroid nodule volume.
• The procedure led to the unexpected onset of Graves disease in a patient without prior autoimmunity.
• Transient thyroiditis and subsequent hyperthyroidism are known RFA risks, but new-onset autoimmunity is a novel concern.

Implications:

• Further research is needed to evaluate the risk of incident hyperthyroidism, specifically Graves disease, following RFA.
• RFA's risk profile may need re-evaluation to include the potential for inducing thyroid autoimmunity.
• Larger studies should investigate the link between RFA and the development of Graves disease.